Biopharmaceuticals are a unique class of compounds due to their extreme structural complexity. The current text puts together a variety of the state of the art approaches that use mass spectrometry to evaluate various aspects of biopharmaceutical products ranging from monitoring stress related structural changes to their quantitation in pharmacokinetic studies.